SUN bioscience

📍 Lausanne, Switzerland🗓 Founded 2016👥 2 employees💰 Last funded Apr 2020
Biotechnology Research🌐 sunbioscience.com
Website LinkedIn
SUN bioscience is enabling personalized medicine through its SUN’s proprietary high-throughput 3D microwell platform. Organoids are self-organizing 3D miniature tissues with organ-mimicking functions that are grown from stem cells. They are powerful human in vitro models for assessing pharmaceutical efficacy and toxicity early on in drug development. Our flagship technology Gri3D® is solving the challenges of organoid culture: automation, robustness, scalability, and easy imaging. This will introduce a new era in drug development.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
2
Frequently asked questions
Who invested in SUN bioscience?
SUN bioscience has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did SUN bioscience last raise funding?
The most recent investment in SUN bioscience recorded on gritt.io was in April 2020.
When was SUN bioscience founded?
SUN bioscience was founded in 2016.
What industry is SUN bioscience in?
SUN bioscience operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is SUN bioscience based?
SUN bioscience is headquartered in Lausanne, Switzerland.